PVT1 serum expression levels—defined by quantitative reverse transcription polymerase chain reaction (qRT-PCR)—revealed a significant increase in patients with melanoma (higher expression in later stages compared to early ones) compared with control group. This evidence concerns the gene PVT1 and melanoma.